Form 8-K · Current report
News Corp 8-K, filed Oct 29, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000239
Summary
News Corp disclosed daily repurchase activity under its 2025 Repurchase Program, which authorizes up to $1 billion in aggregate repurchases of its Class A and Class B common stock. On October 28, 2026 the company bought back 58,482 Class A common shares for about US$1.76 million, bringing total purchases under the program to approximately US$557.8 million.
Key points
- News Corp repurchased 58,482 Class A common shares on October 28, 2026 for total consideration of about US$1,759,512.84, at prices between US$29.00 and US$29.83.
- Total consideration paid under the 2025 Repurchase Program to date is approximately US$557,793,679 of the US$1 billion authorized.
- 357,993,931 Class A common shares were on issue.
- Goldman Sachs & Co. LLC is named as broker for the buy-back, and no security holder approval is required.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.